Rise Advisors’s Ventyx Biosciences VTYX Stock Holding History

Rise Advisors’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-870	Closed	-$2.71K	–	1404
2025 Q3	$2.71K	Hold	870	–	–	﹤0.01%	1170
2025 Q2	$1.86K	Buy	870 +543	+166%	+$877	﹤0.01%	1202
2025 Q1	$376	Buy	+327	New	+$561	﹤0.01%	1410

Other funds holding VTYX

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Rise Advisors's VTYX Position: Q4 2025 in Review

Rise Advisors sold out of Ventyx Biosciences (VTYX) in Q4 2025, closing a stake of 870 shares — an estimated $2.71K sold.

Rise Advisors first reported a position in VTYX in Q1 2025 and held it in 3 quarters. The position peaked at $2.71K in Q3 2025. 139 funds tracked by Wall St. Rank hold VTYX as of Q4 2025.

Rise Advisors reported no remaining Ventyx Biosciences position as of Q4 2025 after selling out during the quarter.
Rise Advisors sold 870 Ventyx Biosciences shares in Q4 2025, an estimated $2.71K.
Rise Advisors first reported a position in Ventyx Biosciences in Q1 2025 and held it in 3 quarters.
Rise Advisors's Ventyx Biosciences position peaked at $2.71K in Q3 2025.
139 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.